Analysts who follow Galmed Pharmaceuticals Ltd (GLMD) on average expect it to rise 506.96% over the next twelve months. Those same analysts give the stock an average rating of Hold.
That average rating earns GLMD an Analyst Ranking of 5, which means it ranks higher than 5 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating GLMD a Hold today. Find out what this means to you and get the rest of the rankings on GLMD!
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With Galmed Pharmaceuticals Ltd Stock Today?
Galmed Pharmaceuticals Ltd (GLMD) stock is trading at $2.47 as of 3:53 PM on Wednesday, Jul 12, a rise of $0.19, or 8.33% from the previous closing price of $2.28. Volume today is above average. So far 5,484,068 shares have traded compared to average volume of 27,581 shares. The stock has traded between $2.30 and $5.47 so far today.
Click Here to get the full Stock Report for Galmed Pharmaceuticals Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
